UOC
UBS O'Connor Portfolio holdings
AUM
$1.93B
1-Year Return
38.75%
This Quarter Return
+15.38%
1 Year Return
+38.75%
3 Year Return
+182.42%
5 Year Return
+480.25%
10 Year Return
+1,573.29%
AUM
$3.3B
AUM Growth
-$463M
(-12%)
Cap. Flow
-$632M
Cap. Flow
% of AUM
-19.12%
Top 10 Holdings %
Top 10 Hldgs %
73.53%
Holding
460
New
59
Increased
65
Reduced
85
Closed
138
Top Buys
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$405M |
| 2 |
DFS
Discover Financial Services
DFS
|
$209M |
| 3 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
$195M |
| 4 |
HEES
H&E Equipment Services
HEES
|
$103M |
| 5 |
JWN
Nordstrom
JWN
|
$96.6M |
Top Sells
| 1 |
Kellanova
K
|
$305M |
| 2 |
HCP
HashiCorp, Inc. Class A Common Stock
HCP
|
$235M |
| 3 |
SMAR
Smartsheet Inc.
SMAR
|
$216M |
| 4 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
$144M |
| 5 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
$103M |
Sector Composition
| 1 | Energy | 21.95% |
| 2 | Financials | 16.66% |
| 3 | Healthcare | 15.59% |
| 4 | Technology | 13.54% |
| 5 | Industrials | 12.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Keros Therapeutics
KROS
$633M
| $1.18M | 0.04% |
115,518
+64,621
| +127% | +$658K |
|
152
Schrodinger
SDGR
$1.41B
| $1.17M | 0.04% |
59,043
+12,129
| +26% | +$239K |
|
153
Mineralys Therapeutics
MLYS
$2.7B
| $1.16M | 0.04% |
73,348
+45,280
| +161% | +$719K |
|
|
DADA
154
DELISTED
Dada Nexus
DADA
| $1.15M | 0.03% |
+618,986
| New | +$1.15M |
|
155
IDEAYA Biosciences
IDYA
$2.38B
| $1.14M | 0.03% |
69,474
-3,242
| -4% | -$53.1K |
|
156
Alchemy Investments Acquisition Corp 1
ALCY
$49.1M
| $1.13M | 0.03% |
100,248
| – | – |
|
157
Dollar Tree
DLTR
$20.6B
| $1.12M | 0.03% |
+14,900
| New | +$1.12M |
|
158
Haymaker Acquisition Corp 4
HYAC
$327M
| $1.1M | 0.03% |
100,248
| – | – |
|
|
VRNA
159
Verona Pharma
VRNA
$9.2B
| $1.09M | 0.03% |
+17,150
| New | +$1.09M |
|
160
Tapestry
TPR
$21.7B
| $1.06M | 0.03% |
+15,000
| New | +$1.06M |
|
161
Nuvation Bio
NUVB
$1.33B
| $1.04M | 0.03% |
+592,119
| New | +$1.04M |
|
|
GAP
162
The Gap, Inc.
GAP
$8.83B
| $1.03M | 0.03% |
+50,000
| New | +$1.03M |
|
163
Merus
MRUS
$5.1B
| $1.02M | 0.03% |
24,232
+9,692
| +67% | +$408K |
|
164
Mirum Pharmaceuticals
MIRM
$3.82B
| $1.02M | 0.03% |
22,560
-2,499
| -10% | -$113K |
|
165
Kroger
KR
$44.8B
| $1.02M | 0.03% |
+15,000
| New | +$1.02M |
|
166
Praxis Precision Medicines
PRAX
$986M
| $1.01M | 0.03% |
26,793
+290
| +1% | +$11K |
|
167
Arcus Biosciences
RCUS
$1.3B
| $1.01M | 0.03% |
128,688
+52,042
| +68% | +$409K |
|
168
Relay Therapeutics
RLAY
$710M
| $1M | 0.03% |
382,900
+52,201
| +16% | +$137K |
|
169
KALA BIO
KALA
$102M
| $979K | 0.03% |
170,917
-8,017
| -4% | -$45.9K |
|
170
Costco
COST
$427B
| $946K | 0.03% |
+1,000
| New | +$946K |
|
171
Terns Pharmaceuticals
TERN
$632M
| $928K | 0.03% |
336,144
+195,844
| +140% | +$541K |
|
172
Annexon
ANNX
$238M
| $901K | 0.03% |
466,819
+147,935
| +46% | +$286K |
|
173
Day One Biopharmaceuticals
DAWN
$773M
| $898K | 0.03% |
113,250
+63,230
| +126% | +$501K |
|
174
Scholar Rock
SRRK
$3.02B
| $888K | 0.03% |
+27,617
| New | +$888K |
|
175
Aura Biosciences
AURA
$403M
| $885K | 0.03% |
151,108
+14,592
| +11% | +$85.5K |
|